(firstQuint)Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated.

 The primary objectives are to assess safety of Rift Valley Fever (RVF) Vaccine, Inactivated (TSI-GSD 200) and to assess immunogenicity of Rift Valley Fever (RVF) Vaccine, Inactivated (TSI-GSD 200).

 The secondary objective is to assess incidence of RVF infection in vaccinated personnel.

 Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated@highlight

This study is designed to determine the safety and immunogenicity of an inactivated Rift Valley Fever (RVF) Vaccine in adults